[
  {
    "ts": "2025-09-14T12:28:55+00:00",
    "headline": "Does Regeneron Offer Value After Recent Share Price Drop in 2025?",
    "summary": "Thinking about what to do with Regeneron Pharmaceuticals’ stock? You are not alone. The past year has been a wild ride, and it has left many investors reevaluating where the company stands. Regeneron’s share price has retreated by 51.2% over the last twelve months. For those who have been holding on even longer, the return over five years is a modest 1.3%. Even so, the stock is still in the spotlight thanks to its innovative biotech pipeline and recent market developments that continue to...",
    "url": "https://finance.yahoo.com/news/does-regeneron-offer-value-recent-122855664.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c0e6ad8d-ad97-3c0f-82fc-25682e7762a5",
      "content": {
        "id": "c0e6ad8d-ad97-3c0f-82fc-25682e7762a5",
        "contentType": "STORY",
        "title": "Does Regeneron Offer Value After Recent Share Price Drop in 2025?",
        "description": "",
        "summary": "Thinking about what to do with Regeneron Pharmaceuticals’ stock? You are not alone. The past year has been a wild ride, and it has left many investors reevaluating where the company stands. Regeneron’s share price has retreated by 51.2% over the last twelve months. For those who have been holding on even longer, the return over five years is a modest 1.3%. Even so, the stock is still in the spotlight thanks to its innovative biotech pipeline and recent market developments that continue to...",
        "pubDate": "2025-09-14T12:28:55Z",
        "displayTime": "2025-09-14T12:28:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w30LARiR1Z35GusfaFi.2g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3eDp_RSETU8kXm3usDK_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-regeneron-offer-value-recent-122855664.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-regeneron-offer-value-recent-122855664.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-14T05:17:06+00:00",
    "headline": "BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN), Sets a $640 PT",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best cheap stocks to buy for beginners. In a report released on September 8, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), setting a price target of $640.00. The analyst cited various factors supporting the optimistic outlook, including the promising results […]",
    "url": "https://finance.yahoo.com/news/bmo-capital-maintains-buy-regeneron-051706841.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "fc326f9c-fe64-3478-bc12-5380e12f2839",
      "content": {
        "id": "fc326f9c-fe64-3478-bc12-5380e12f2839",
        "contentType": "STORY",
        "title": "BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN), Sets a $640 PT",
        "description": "",
        "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best cheap stocks to buy for beginners. In a report released on September 8, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), setting a price target of $640.00. The analyst cited various factors supporting the optimistic outlook, including the promising results […]",
        "pubDate": "2025-09-14T05:17:06Z",
        "displayTime": "2025-09-14T05:17:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Regeneron Pharmaceuticals, Inc. (REGN) Crashed Last Week",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xYTEe3VE6sgZxe9COOwZXw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ku0XeMdDvNCP8FVlwzrrCw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmo-capital-maintains-buy-regeneron-051706841.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmo-capital-maintains-buy-regeneron-051706841.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]